OTCMKTS:IVOB - INVO Bioscience Stock Price, Price Target & More

$0.68 -0.02 (-2.37 %)
(As of 04/26/2018 04:00 PM ET)
Previous Close$0.6965
Today's Range$0.61 - $0.70
52-Week Range$0.08 - $0.77
Volume41,200 shs
Average Volume92,248 shs
Market Capitalization$99.56 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.63

About INVO Bioscience (OTCMKTS:IVOB)

INVO Bioscience, Inc., a medical device company, provides novel solutions in assisted reproductive technologies to the reproductive health care community in the United States, Canada, South and Central America, Latin America, India, the Middle East, and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVO procedure, an alternative infertility treatment that enables the conception and embryo development inside the woman's body. The company sells its products through established and new distributors, IVF centers, and physicians, as well as directly to the physicians. INVO Bioscience, Inc. is based in Medford, Massachusetts.

Receive IVOB News and Ratings via Email

Sign-up to receive the latest news and ratings for IVOB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:IVOB
CUSIPN/A
Phone978-878-9505

Debt

Debt-to-Equity Ratio-0.03%
Current Ratio0.04%
Quick Ratio0.04%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$280,000.00
Price / Sales349.20
Cash FlowN/A
Price / CashN/A
Book Value($0.04) per share
Price / Book-17.00

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-700,000.00
Net Margins-106.41%
Return on EquityN/A
Return on Assets-144.58%

Miscellaneous

Employees1
Outstanding Shares143,790,000

INVO Bioscience (OTCMKTS:IVOB) Frequently Asked Questions

What is INVO Bioscience's stock symbol?

INVO Bioscience trades on the OTCMKTS under the ticker symbol "IVOB."

How were INVO Bioscience's earnings last quarter?

INVO Bioscience (OTCMKTS:IVOB) announced its earnings results on Monday, May, 15th. The company reported $0.00 EPS for the quarter. The firm earned $0.05 million during the quarter. View INVO Bioscience's Earnings History.

When is INVO Bioscience's next earnings date?

INVO Bioscience is scheduled to release their next quarterly earnings announcement on Monday, May, 21st 2018. View Earnings Estimates for INVO Bioscience.

Who are some of INVO Bioscience's key competitors?

Who are INVO Bioscience's key executives?

INVO Bioscience's management team includes the folowing people:
  • Ms. Kathleen T. Karloff, Co-Founder, Chairman, Chief Exec. Officer and Pres (Age 63)
  • Mr. Robert Joseph Bowdring Jr., Acting Chief Financial Officer, Treasurer, Sec., Consultant and Director (Age 60)

Has INVO Bioscience been receiving favorable news coverage?

Media stories about IVOB stock have trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. INVO Bioscience earned a coverage optimism score of 0.04 on Accern's scale. They also assigned news coverage about the company an impact score of 47.23 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of INVO Bioscience?

Shares of IVOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is INVO Bioscience's stock price today?

One share of IVOB stock can currently be purchased for approximately $0.68.

How big of a company is INVO Bioscience?

INVO Bioscience has a market capitalization of $99.56 million and generates $280,000.00 in revenue each year. INVO Bioscience employs 1 workers across the globe.

How can I contact INVO Bioscience?

INVO Bioscience's mailing address is 407R MYSTIC AVENUE SUITE 34C, MEDFORD MA, 02155. The company can be reached via phone at 978-878-9505 or via email at [email protected]


MarketBeat Community Rating for INVO Bioscience (IVOB)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  46 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  83
MarketBeat's community ratings are surveys of what our community members think about INVO Bioscience and other stocks. Vote "Outperform" if you believe IVOB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVOB will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

INVO Bioscience (OTCMKTS:IVOB) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/26/2016 forward)

Earnings

INVO Bioscience (OTCMKTS:IVOB) Earnings History and Estimates Chart

Earnings by Quarter for INVO Bioscience (OTCMKTS:IVOB)

INVO Bioscience (OTCMKTS IVOB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/21/2018        
5/15/2017Q1 2017($0.0010)$0.05 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

INVO Bioscience (OTCMKTS:IVOB) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

INVO Bioscience (OTCMKTS IVOB) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 0.04%
Insider Trading History for INVO Bioscience (OTCMKTS:IVOB)

INVO Bioscience (OTCMKTS IVOB) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2018Claude RanouxMajor ShareholderSell13,642$0.18$2,455.56View SEC Filing  
2/23/2018Claude RanouxMajor ShareholderSell100$0.18$18.00View SEC Filing  
2/21/2018Claude RanouxMajor ShareholderSell122,322$0.11$13,455.42View SEC Filing  
2/16/2018Claude RanouxMajor ShareholderSell13,890$0.11$1,527.90View SEC Filing  
2/13/2018Claude RanouxMajor ShareholderSell12,808$0.11$1,408.88View SEC Filing  
2/7/2018Claude RanouxMajor ShareholderSell16,115$0.11$1,772.65View SEC Filing  
2/2/2018Claude RanouxMajor ShareholderSell18,700$0.12$2,244.00View SEC Filing  
1/29/2018Claude RanouxMajor ShareholderSell31,319$0.12$3,758.28View SEC Filing  
1/25/2018Claude RanouxMajor ShareholderSell2,100$0.12$252.00View SEC Filing  
1/22/2018Claude RanouxMajor ShareholderSell46,500$0.12$5,580.00View SEC Filing  
1/16/2018Claude RanouxMajor ShareholderSell600$0.15$90.00View SEC Filing  
1/12/2018Claude RanouxMajor ShareholderSell12,545$0.15$1,881.75View SEC Filing  
1/8/2018Claude RanouxMajor ShareholderSell100,000$0.13$13,000.00View SEC Filing  
1/4/2018Claude RanouxMajor ShareholderSell2,834$0.15$425.10View SEC Filing  
12/29/2017Claude RanouxMajor ShareholderSell4,525$0.16$724.00View SEC Filing  
12/27/2017Claude RanouxMajor ShareholderSell10,000$0.17$1,700.00View SEC Filing  
12/20/2017Claude RanouxMajor ShareholderSell10,000$0.17$1,700.00View SEC Filing  
12/18/2017Claude RanouxMajor ShareholderSell30,000$0.17$5,100.00View SEC Filing  
12/11/2017Claude RanouxMajor ShareholderSell50,000$0.18$9,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

INVO Bioscience (OTCMKTS IVOB) News Headlines

Source:
DateHeadline
The Fertility Institute of New Orleans Expands Reproductive Services with INVOcellThe Fertility Institute of New Orleans Expands Reproductive Services with INVOcell
finance.yahoo.com - April 24 at 9:44 AM
America Institute of Reproductive Medicine - Alabama Adds INVOcell to its Scope of ServicesAmerica Institute of Reproductive Medicine - Alabama Adds INVOcell to its Scope of Services
finance.yahoo.com - April 10 at 10:12 AM
Fertility Institute of Hawaii becomes First Fertility Clinic in Hawaii to Adopt INVOcellFertility Institute of Hawaii becomes First Fertility Clinic in Hawaii to Adopt INVOcell
finance.yahoo.com - April 3 at 10:08 AM
INVO Bioscience Reports Year End 2017 Financial ResultsINVO Bioscience Reports Year End 2017 Financial Results
finance.yahoo.com - March 29 at 10:13 AM
Palm Beach Fertility Center Expands its Scope of Reproductive Services with INVOCell as INVO Bioscience Enters FloridaPalm Beach Fertility Center Expands its Scope of Reproductive Services with INVOCell as INVO Bioscience Enters Florida
finance.yahoo.com - March 20 at 9:59 AM
INVO Bioscience Expands its Training CapacityINVO Bioscience Expands its Training Capacity
finance.yahoo.com - March 13 at 10:14 AM
INVOcell Fertility Treatment Now Offered at Family Beginnings in IndianapolisINVOcell Fertility Treatment Now Offered at Family Beginnings in Indianapolis
finance.yahoo.com - March 6 at 9:40 AM
INVO Bioscience Progresses in Developing Market for INVOcell in Hong Kong and MacaoINVO Bioscience Progresses in Developing Market for INVOcell in Hong Kong and Macao
finance.yahoo.com - February 28 at 9:41 AM
Claude Ranoux Sells 122,322 Shares of Invo Bioscience Inc (IVOB) StockClaude Ranoux Sells 122,322 Shares of Invo Bioscience Inc (IVOB) Stock
www.americanbankingnews.com - February 22 at 7:26 PM
Alabama Fertility Breaking New Ground to be the First to Offer INVOcell in AlabamaAlabama Fertility Breaking New Ground to be the First to Offer INVOcell in Alabama
finance.yahoo.com - February 20 at 9:19 AM
Carolina Conceptions Expands its Menu of Reproductive Services with INVOcellCarolina Conceptions Expands its Menu of Reproductive Services with INVOcell
finance.yahoo.com - February 8 at 9:07 AM
Invo Bioscience Inc (IVOB) Major Shareholder Claude Ranoux Sells 100,000 SharesInvo Bioscience Inc (IVOB) Major Shareholder Claude Ranoux Sells 100,000 Shares
www.americanbankingnews.com - January 9 at 7:56 PM
INVO Bioscience Reports Third Quarter 2017 Financial ResultsINVO Bioscience Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 15 at 3:24 AM
INVO Bioscience Appoints Michael J. Campbell and Steven Shum to Its Board of DirectorsINVO Bioscience Appoints Michael J. Campbell and Steven Shum to Its Board of Directors
finance.yahoo.com - October 11 at 4:48 PM
First INVO Babies Born in CaliforniaFirst INVO Babies Born in California
finance.yahoo.com - September 25 at 9:23 AM
Dr. Francisco Arredondo Opens First U.S. INVOcell Center in McAllen, TexasDr. Francisco Arredondo Opens First U.S. INVOcell Center in McAllen, Texas
finance.yahoo.com - September 6 at 7:59 PM
INVO Bioscience Reports Record Second Quarter 2017 Financial ResultsINVO Bioscience Reports Record Second Quarter 2017 Financial Results
finance.yahoo.com - August 11 at 4:37 AM
INVOcell Fertility Treatment Now Offered at the Center for Reproductive Health at Tri-Star Centennial Medical Center in NashvilleINVOcell Fertility Treatment Now Offered at the Center for Reproductive Health at Tri-Star Centennial Medical Center in Nashville
finance.yahoo.com - August 3 at 8:14 PM
Piedmont Reproductive Endocrinology Group in South Carolina Successfully Launches INVOcellPiedmont Reproductive Endocrinology Group in South Carolina Successfully Launches INVOcell
finance.yahoo.com - August 2 at 1:34 AM
Houston Fertility Center to Begin Offering INVOcell Procedure to Patients in Southeast TexasHouston Fertility Center to Begin Offering INVOcell Procedure to Patients in Southeast Texas
finance.yahoo.com - July 19 at 10:40 PM
The Atlantic Magazine Publishes Article on Breakthrough IVF Treatment by INVO BioscienceThe Atlantic Magazine Publishes Article on Breakthrough IVF Treatment by INVO Bioscience
finance.yahoo.com - July 14 at 4:44 AM
INVO BIOSCIENCE, INC. Files SEC form 10-K, Annual ReportINVO BIOSCIENCE, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 17 at 6:14 PM
INVO BIOSCIENCE, INC. Files SEC form 8-K, Changes in Registrants Certifying Accountant, Amendments to Articles of InINVO BIOSCIENCE, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Amendments to Articles of In
biz.yahoo.com - January 6 at 6:39 PM
INVO BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal OfficersINVO BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - September 26 at 5:47 PM
INVO BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsINVO BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - November 3 at 11:59 AM

SEC Filings

INVO Bioscience (OTCMKTS:IVOB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

INVO Bioscience (OTCMKTS IVOB) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.